Community exposure related to seropositivity of SARS-CoV-2 in HCW

HealthDay News – According to a study published online March 10 on JAMA Network Open, exposures of the community, but not workplace factors, are related to coronavirus 2 (SARS-CoV-2) seropositivity in Severe Acute Respiratory Syndrome (SARS-CoV- 2) connected.

Jesse T. Jacob, MD of Emory University in Atlanta and colleagues conducted a cross-sectional study of HCP in four major health systems in three US states to assess the risk factors associated with SARS-CoV-2 seropositivity. Data were included for 24,749 HCP; 50.2 percent said they were in contact with patients with COVID-19 in the workplace.

The researchers found that the cumulative incidence of COVID-19 in the community up to a week before the serology test was between 8.2 and 275.6 per 10,000; 81.1 percent of the HCP stated that they had no COVID-19 contact in the community. Overall, the seropositivity was 4.4 percent. Community COVID-19 contact and community COVID-19 cumulative incidence were associated with seropositivity in a multivariable analysis (adjusted odds ratios, 3.5 and 1.8, respectively). None of the workplace factors studied were associated with seropositivity, including the role of the nurse, work in the emergency room, or workplace contact with patients with COVID-19.

“These results reassure that current methods of infection prevention are effective in similar health systems and that the greatest risks can come from community exposures,” the authors write.

Several authors have disclosed financial relationships with the pharmaceutical industry.

Abstract / full text



COVID19 General Infectious Disease General Management of the Neurology Practice

Related Articles